Synthetic Biologics’ Board of Directors Accepts Resignation of Long-Standing Founder and Board Member

[PR Newswire] – ROCKVILLE, Md., Feb. 26, 2014 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, announced t more

View todays social media effects on SYN

View the latest stocks trending across Twitter. Click to view dashboard

See who Synthetic is hiring next, click here to view